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1. Introduction  
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 
(CADASIL) is the most common hereditary subcortical vascular dementia. CADASIL is 
caused by mutations in NOTCH3 gene, which encodes a large transmembrane receptor 
NOTCH3. The key pathological finding is the accumulation of granular osmiophilic material 
(GOM), which contains extracellular domains of NOTCH3, on degenerating vascular smooth 
muscle cells (VSMCs). CADASIL is usually suspected on the basis of patient’s clinical picture, 
relatively characteristic findings in brain MRI and  information on family history. Definite 
diagnosis can be established by molecular genetic detection of a pathogenic mutation in 
NOTCH3 gene. The gene analysis may, however, be laborious, due to the high number of 
different pathogenic mutations (over 200 at present) and besides, comprehensive genetic 
analyses are available only in few genetic laboratories. However,  CADASIL is a unique 
dementing disorder, because it is also possible to diagnose it at a high level of certainty by a 
skin biopsy using electron microscopic (EM) or immunohistochemical (IHC) analysis of 
dermal arteries.  
2. CADASIL  
2.1 Epidemiology 
CADASIL, the most common hereditary vascular dementia, is characterized by migraineous 
headache with aura, recurrent ischemic attacks, cognitive decline and psychiatric symptoms 
as the four main features. Migraneous headache with aura occurs in about one third of 
patients and it may begin already before the age of 10 years (Kalimo et al., 2008). The age at 
first ever stroke varies widely, usually from 25 to 65 years [yet, the youngest patient who 
has suffered from a stroke was 11 years-of-age (Granild-Jensen et al., 2009)]. 
2.2 Etiology 
CADASIL is caused by mutations in NOTCH3 gene encoding a transmembrane receptor 
NOTCH3 (Joutel et al., 1996). Virtually all pathogenic mutations lead to an odd number of 
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cysteine residues in one of the 34 epidermal growth factor (EGF) like repeats in the 
extracellular domain of NOTCH3 (N3ECD). The mutations result in degeneration of vascular 
smooth muscle cells (VSMC), in which NOTCH3 is predominantly expressed in adult humans 
(Joutel et al., 2000). The main pathological findings are accumulation of N3ECD on 
degenerating VSMCs as well as fibrosis and thickening of arterial walls, stenosis of arterioles 
and lacunar infarcts (Miao et al., 2004, Ruchoux et al., 1995). In electron microscopy (EM) the 
pathognomonic feature of CADASIL is accumulation of granular osmiophilic material (GOM) 
in indentations of the VSMCs or in the extracellular space in close vicinity to VSMCs 
(Baudrimont et al., 1993, Ruchoux et al., 1995). The exact composition of GOM has not been 
elaborated, but an immunogold EM study suggested N3ECD to be a component of GOM 
(Ishiko et al., 2006). 
 
 
Fig. 1. Histopathological findings in CADASIL brain arteries. A) Small arteriole from the 
cerebral white matter of a control person. H&E staining. B) Corresponding arteriole from a 
CADASIL patient. Note the marked thickening of the wall. H&E staining. C) Degeneration 
of VSMCs is seen as decreased immunoreactivity for -SMA. D) N3ECD has accumulated in 
the tunica media of an affected arteriole.  
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2.3 Vascular pathology 
2.3.1 Brain arteries 
Pathological changes are present in all small to medium-sized arteries of the body and in 
some veins and capillaries. In small arterioles in cerebral white matter (WM) histological 
stainings reveal markedly thickened walls with accumulation of N3ECD in the degenerating 
tunica media. This material is basophilic in H&E (Figure 1A and B) and red in PAS 
stainings. Decreased immunopositivity for -smooth muscle actin (-SMA) reveals 
degeneration of the VSMCs (Figure 1C). The accumulation of N3ECD can be verified by 
immunohistochemical staining (Figure 1D). Accumulation of extracellular matrix proteins, 
including various types of collagens and fibronectin and vimentin outside the degenerating 
VSMCs causes the thickening of the vessel walls (Figures 1A-D). On the basis of the 
stainings above CADASIL can be distinguished from the two other arteriopathies with 
thickened walls: In arteriolosclerosis (Binswanger disease) and cerebral amyloid angiopathy 
the walls are homogeneously stained, either like collagen or like amyloid. The brain arteries 
are usually not studied until post mortem, when the degeneration of VSMCs and the 
accumulation of GOM are already obvious at the LM level. Thus, EM examination is not 
needed and is  usually not performed. 
2.3.2 Dermal arterioles - appearance of GOM 
Skin biopsies are most often performed and the specimens examined at earlier stages of 
CADASIL, often when the diagnosis is only suspected. In histological sections the skin 
usually looks relatively normal: the possible thickening of the walls of small arteries within 
the dermal connective tissue is difficult to discern. Thus, either EM or IHC examination is 
needed.  
EM analysis of an arterial wall reveals enlarged subendothelial space and the degenerating 
VSMCs which appear irregularly shaped as they have lost their intercellular connections 
(Figure 2; Ruchoux and Maurage, 1997, Kalimo et al., 2008). As a striking and pathognomonic 
feature of CADASIL, GOM accumulates on VSMCs (Baudrimont et al., 1993, Ruchoux et al., 
1995). Already before the gene defect was found, GOM was detected in skin biopsies from 
CADASIL patients (Ruchoux et al., 1994). So far GOM has not been described in any other 
disease entity: GOM is negative in both histological (e.g. Congo red and thioflavin) and 
immunohistochemical stainings for different amyloid angiopathies (Ragno et al., 1995, 
Ruchoux and Maurage, 1997). GOM accumulates in the arterial wall, in the tunica media and is 
usually detected in the close vicinity to VSMCs, often in small indentations of VSMC plasma 
membrane within the basal lamina (Figures 2 and 3A), which is usually irregularly thickened, 
or GOM lies free in the extracellular space (Figures 2 and 6C.). The indentations are often 
associated with caveolar structures (Figure 3A), but as caveolae are common structures of 
VSMCs, their pathogenetic significance is unclear. The size of GOM deposits is variable, 
ranging from 0.2 µm to 0.8 µm, and they are composed of 10-15 nm granules  (Ruchoux and 
Maurage, 1997). GOM appears in EM as evenly electron dense or, as often, denser on the side 
which is towards the VSMC membrane (Figure  3A). The exact composition of GOM has not 
been fully clarified, but N3ECD is a component of GOM as demonstrated by immunoelectron 
microscopy (Ishiko et al., 2006). Moreover, with confocal microscopy, N3ECD 
immunoreactivity can be seen as dot-like accumulations on the arterial wall, in concordance 
with the appearance of GOM deposits in the EM (Figure 3B). The degeneration of VSMCs and 
the accumulation of GOM begin early and the morphological changes in arteries and the 
accumulation of GOM are already detectable before the age of 20 (Tikka et al., 2009)( Figure 3C ).  
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Fig. 2. EM micrograph of a dermal artery from a CADASIL patient. Characteristic vascular 
pathology is clearly detectable already in early age. Subendothelial space is widened 
(asterisks) and VSMCs are irregularly shaped and have lost their intercellular connections. 
Accumulation of GOM is seen in close vicinity of VSMCs. CADASIL patient with 
pArg133Cys mutation. L=arterial lumen, E=endothelial cell, VSMC=vascular smooth muscle 
cell. Two GOMs are pointed with arrowheads. Figure is reproduced with permission from 
Future Neurology (Kalimo et al., 2008) 
 
 
Fig. 3. Dermal artery of CADASIL patient. A) EM micrograph of CADASIL patient 
(p.Arg133C) showing characteristic GOM deposits in the intendation of VSMC with 
caveolar structures. B) Confocal microscopy reveals N3ECD immunoreactivity as dot-like 
accumulations in the arterial wall in concordance with GOM deposits. A 62 year-old patient 
carrying p.Tyr1069Cys mutation. C) Accumulation of GOM in an artery of 19 year-old 
CADASIL patient with mutation p.Arg133Cys. Figure B is reproduced with permission 
from Future Neurology (Kalimo et al., 2008) 
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3. Diagnosis of CADASIL 
3.1 Clinical findings 
CADASIL is suspected in patients with the typical clinical features, occasionally with 
positive family history. Patients are sometimes hypertensive, but it does not have any 
diagnostic significance.  White matter alterations in brain T2-weighted MRI (O'Sullivan et 
al., 2001) are important clues. In T2w MRI an experienced radiologist can detect changes 
that are highly suggestive of CADASIL already in asymptomatic carriers of the gene defect 
(even before the age of 20). Hyperintensities on T2w and FLAIR MRI in temporopolar WM 
are nearly diagnostic of CADASIL (Figures 4A). In addition, cerebral periventricular WM 
and capsula externa hyperintensities are characteristic (Figure 4B; Chabriat et al., 1998). 
Laboratory examinations are usually non-rewarding or non-specific, i.e. the examinations 
may reveal risk factors of other cerebrovascular diseases.  
 
 
Fig. 4. MRI findings in CADASIL. Hyperintensities in anterior temporal lobes in  
T2-weighted MRI are characteristic early alterations in CADASIL. A 29-year-old female  
soon after her first transient ischemic attack. B) At an advanced stage of CADASIL FLAIR 
MRI shows extensive hyperintensities in the cerebral white matter (leukoaraiosis).  
Figure 4A is reproduced with permission of Future Neurology (Kalimo et al., 2008) 
3.2 Genetic analysis 
The definite verification of the diagnosis can be done by identifying a pathogenic mutation 
in the NOTCH3 gene. However, over 200 different mutations in 20 different exons have been 
reported to cause CADASIL (Tikka et al., 2009, Junna et al. 2011 unpublished). 
Comprehensive analysis of all these exons is time consuming and costly. Thus, most 
diagnostic laboratories screen only the exons that according to the previous reports harbour 
majority of the mutations (Dotti et al., 2005, Escary et al., 2000, Joutel et al., 1997, Kalimo et 
al., 2002, Opherk et al., 2004). Of the all reported pathogenic NOTCH3 mutations 62% locate 
www.intechopen.com
 Skin Biopsy – Perspectives 188 
in exons 3, 4, 5 and 8. Furthermore, to obtain 80 % coverage, additional investigation of 
exons 2, 6, 11 and 18 is required (Tikka et al., 2009). Mutation screening covering the whole 
region coding for EGF repeats (exons 2-24) is not realistic for all patients and for most 
laboratories. 
3.3 Skin biopsy  
Given the challenging factors complicating comprehensive genetic analyses it is fortunate 
that CADASIL is also possible to diagnose by skin biopsy using EM or IHC examination.  
3.3.1 EM analysis 
Although GOM has not been detected in any other disease and the specificity is considered 
to be 100% (Ebke et al., 1997, Mayer et al., 1999, Markus et al., 2002, Razvi et al., 2003) the 
reports on the sensitivity of detecting GOM in skin biopsy of patients with genetically 
verified CADASIL have been contradictory. Two earlier studies on a smaller number of 
patients suggested 100% sensitivity (Ebke et al., 1997, Mayer et al., 1999) in which Ebke et al. 
analysed one family with 8 patients (mutation not specified) and 5 controls suffering from 
sporadic leukoencephalopathies and Mayer et al. examined 14 patients (mutation not 
specified) from three unrelated families. Two more recent papers have reported a low 
sensitivity: Markus et al. (2002) reported GOM detected only in 8 patients out of 18, thus 
giving a sensitivity of only 44.4%. Razvi et al. (2003) suspected that the sensitivity might be 
even lower, although they did not give an exact number. In the latest EM study in a cohort 
of 131 CADASIL patients and 26 control subjects GOM was detected in all skin biopsies 
from mutation positive patients and in none of the control biopsies (Tikka et al., 2009). This 
study was a retrospective investigation of a combined patient material from Finland, 
Sweden and France comprising 131 patients, from whom both the genetic analysis and EM 
examination of skin biopsy were available. Skin biopsies from 26 mutation negative 
members in genetically proven CADASIL families served as controls.  
This study showed that EM demonstration of GOM in skin biopsy is a highly reliable and 
practical method to screen for or even specifically diagnose CADASIL. Furthermore, the 
intensive search for mutations based on confidence in the diagnostic specificity of GOM 
resulted in discovery of four novel, previously unreported mutations, among them the first 
duplication of three codons (Tikka et al., 2009). Thus the detection of GOM in skin biopsies 
is a highly reliable diagnostic method: in this large cohort the congruence between NOTCH3 
mutations and presence of GOM was 100% (Tikka et al., 2009). 
Technical requirements 
When using EM analysis of skin biopsy as a diagnostic method in suspected CADASIL 
cases, special attention should be paid to the quality and analysis of the skin biopsy. The 
GOM is best detectable generally from medium sized or small arterioles (usually outer 
diameter 20-40 µm) in deep dermis or upper subcutis, but in a few cases GOM has been 
detected also in veins (Tikka et al. 2009, Fig. 6B) and capillaries (Lewandowska et al., 
2010). The detection of fragmented lamina elastica interna as dark blue dots in toluidine 
blue semithin sections (Figure 5) is a good marker of representative arterioles. Technical 
factors in the processing of the samples may also influence the result. Since GOM is 
osmiophilic, the osmium tetroxide treatment should be adjusted such that GOM becomes 
sufficiently well contrasted. Furthermore, if GOM is not detected in the first vessel 
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investigated, other vessels or even repeat biopsies should be examined. Besides, 
examination should be targeted rather to an artery/arteriole (with multiple layers of 
VSMCs and inner elastic lamina) than a vein or a capillary, since veins and capillaries are 
not always GOM positive (Figure 6). Of course, a prerequisite is that the investigator 
recognizes GOM correctly and distinguishes it from fallacious deposits like small clumps 
of cell debris or fragmented ECM proteins (Figure 7). 
 
 
Fig. 5. Small arteriole and vein in skin biopsy. Note the thicker vessel wall and fragmented 
lamina elastica (dark blue dots beneath endothelial cell layer) in the arteriole. Toluide blue 
stained semithin epon section of a skin biopsy from CADASIL patient carrying p.Arg133Cys 
mutation. Figure is reproduced with permission of Brain (Tikka et al., 2009). 
3.3.2 Immunohistochemistry 
IHC showing accumulation of N3ECD in the tunica media of small arteries is another 
microscopic method to diagnose CADASIL, the availability of IHC being, of course, better 
than that of EM. Joutel et al. (2001) introduced IHC as a diagnostic tool in CADASIL. In 
that study they showed in a cohort of 39 patients (23 patients, 16 controls) that sensitivity 
of N3ECD staining was 96% and specificity 100%. Another study with a cohort of 41 
NOTCH3 mutation carriers, 21 controls and 10 hereditary cerebral hemorrhage with 
amyloidosis-Dutch (HCHWA-D) patients reported sensitivity of 85.4-90.2% and 
specificity of 95.2-100% (Lesnik Oberstein et al., 2003). Both studies reported false 
negatives which were associated with mutations in exon 11 (Joutel et al., 2001, Lesnik 
Oberstein et al., 2003). In addition, nonspecific staining is an inherent caveat of IHC 
producing false positives  (Lesnik Oberstein et al., 2003). In the latest 
immunohistochemical study on 93 skin biopsies from subjects with suspected CADASIL 
the sensitivity and specificity of the skin biopsies were 97.7% and 56.5%, respectively 
though in familial cases the values improved to 100% and 81.5% (Ampuero et al., 2009).  
Specificity was limited in that study by incomplete sequencing of NOTCH3 (sequenced 
exons: 2-6, 8, 11, 14, 18, 19, 22 and 23). Although IHC is relatively sensitive and highly 
specific, given the possibility of false negatives and positives, it should not be used as 
definitive tool for diagnostics but to help other methods of choice.  
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Fig. 6.  GOM is usually detected in small arteries or arterioles and sometimes in veins and 
capillaries. A) The same vein as in figure 5 with no GOM. B) A vein from deep dermis showing 
one definite GOM (arrow) shown with higher magnification in the inset. C ) The same arteriole 
as in figure 5 with several GOM deposits (five shown with arrows), one marked with asterisk 
is in the inset with higher magnification. L=lumen, E=endothelial cell, M=vascular smooth 
muscle cell. Figure is reproduced with permission of Brain (Tikka et al., 2009). 
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Fig. 7. Fallacious deposits which may lead the electron microscopist astray. A) A true GOM 
deposits with exceptional mushroom-like form (arrows) in CADASIL skin biopsy. Note the 
characteristic fine granular appearance of GOM. B) Fragments of elastica interna (ELA) and 
granular fibrillin network (F) in the widened subendothelial space in skin biopsy of a 
CADASIL suspect with no GOM and no NOTCH3 mutation. C) Granular debris (asterisk) of 
unknown origin. D) Similar granular material as in C) (arrow) with misleading location in 
an indentation of VSMC. E and F) Small clumps of cell debris of different composition 
(arrows) possibly from degenerated cells. L=lumen, E=endothelial cell, M=vascular smooth 
muscle cell. Figure is reproduced with permission of Brain (Tikka et al., 2009). 
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3.4 Diagnostic workflow 
What would be the most efficient strategy to confirm the clinical suspicion of CADASIL? 
Strategy strongly depends on the family history of patient and the mutational background 
in the population to which the suspected patient belongs. In families with a known 
mutation, the method of choice is, of course, to analyse directly that mutation. If the 
patient´s population harbours known founder or major mutations, the diagnostic workup is 
best to begin by first screening for those mutations. In populations with no known founder 
or other prevailing mutations, screening of the known mutational hot spot region of the 
NOTCH3 gene should be the first genetic method to search for CADASIL. To obtain 80 % 
coverage of the reported CADASIL mutations investigation of exons 2-4, 5, 6, 8, 11 and 18 is 
required (Tikka et al., 2009 Supplement table 1). After these analyses EM or IHC analysis of 
a skin biopsy for detection of GOM or accumulation of N3ECD is highly recommended. 
Similar approach has been suggested by Peters et al. (2005). Mutation screening covering the 
whole region coding for EGF repeats (exons 2-24) is not realistic for all suspected patients 
and for most diagnostic laboratories. 
N3ECD the immunostaining has been found reliable method in cases with at least a fair 
amount of accumulated N3ECD (Joutel et al., 2001). However, if only a small amount of the 
N3ECD has accumulated, e.g. at the early stage of the disease, ultrastructural resolution and 
characteristic appearance of GOM most likely make the EM analysis more reliable.  We have 
detected GOM even in patients below the age of 20 years (Figure 3C). Besides, nonspecific 
staining producing false positives is an inherent caveat of immunohistochemistry (Lesnik 
Oberstein et al., 2003), which may cause problems also in CADASIL cases with only small 
amounts of N3ECD giving rise to false negatives. Moreover, EM examination provides also 
information about other pathological changes in the arterial wall, such as those due to 
hypertension, ageing and possibly even other hereditary arteriopathies (Brulin et al., 2002, 
Ruchoux et al., 2000, Ruchoux et al., 2002). The Swedish family with multi-infarct dementia 
was previously thought to be the first published pedigree with CADASIL (Sourander and 
Walinder, 1977). The absence of GOM in the arteries was an important piece of evidence in 
addition to the negative genetic analyses in the demonstration that this family suffers from 
another hereditary vascular dementia (Low et al., 2007). On the other hand, another cerebral 
small vessels disease caused by a novel type of pathogenic mutation (p.Leu1515Pro) in the 
exon 25 of NOTCH3 outside the EGF like repeat rich domain, results in  constitutively active 
NOTCH3 receptor (Fouillade et al., 2008). This leads to increased signaling in a ligand-
independent fashion, possibly due to destabilization of the NOTCH3 heterodimer. Remarkably, 
in this single patient reported there is no deposition of N3ECD and GOM on VSMCs. 
4. Conclusion 
The strategy of the CADASIL workup should be based on logical evaluation of clinical 
findings, family history as well as on both genetic and morphological methods available. 
Demonstration of a known pathogenic mutation provides indisputable evidence for the 
disease and gives a practical tool to clarify genetic counselling in the family. In those cases, in 
which the mutation is not easy to identify or genetic analysis is not available, skin biopsy is 
easy to perform. IHC showing accumulation of N3ECD can also be used as a supportive 
method in diagnostic process although it should not be used as only method. Detection of 
GOM by EM should be preferable method when analysing skin biopsies given its high 
specificity and sensitivity. Neither is it time consuming nor excessively expensive. 
Importantly, it is invaluable in guiding, how far one should proceed with the genetic analyses.  
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